See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Advancing Translational Research in Alzheimer’s Disease

Summary by Inside Precision Medicine
Recently Alamar Biosciences, the Alzheimer’s Disease Data Initiative (ADDI), and Gates Ventures announced a new strategic partnership aimed at creating one of the largest datasets of proteomic and clinical data for Alzheimer’s disease. The international project will profile over 40,000 plasma samples from individuals with Alzheimer’s and related dementias. This ambitious effort aims to accelerate the discovery of new biomarkers and provide deepe…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Inside Precision MedicineInside Precision Medicine

Advancing Translational Research in Alzheimer’s Disease

Recently Alamar Biosciences, the Alzheimer’s Disease Data Initiative (ADDI), and Gates Ventures announced a new strategic partnership aimed at creating one of the largest datasets of proteomic and clinical data for Alzheimer’s disease. The international project will profile over 40,000 plasma samples from individuals with Alzheimer’s and related dementias. This ambitious effort aims to accelerate the discovery of new biomarkers and provide deepe…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news in on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

News
For You
SearchBlindspotLocal